<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pmj</journal-id><journal-title-group><journal-title xml:lang="ru">Тихоокеанский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Pacific Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1609-1175</issn><publisher><publisher-name>TGMU</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17238/PmJ1609-1175.2018.4.34-37</article-id><article-id custom-type="elpub" pub-id-type="custom">pmj-279</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCHES</subject></subj-group></article-categories><title-group><article-title>Особенности интерферонового статуса у пациентов с опоясывающим герпесом</article-title><trans-title-group xml:lang="en"><trans-title>Features of interferon system in patients with herpes zoster</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кныш</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Knysh</surname><given-names>S. V.</given-names></name></name-alternatives><email xlink:type="simple">knysh.sergey@tafimed.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Малков</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Malkov</surname><given-names>V. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Просекова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Prosekova</surname><given-names>E. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ковальчук</surname><given-names>В. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Kovalchuk</surname><given-names>V. K.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Тихоокеанский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pacific State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>28</day><month>12</month><year>2018</year></pub-date><volume>0</volume><issue>4</issue><fpage>34</fpage><lpage>36</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кныш С.В., Малков В.А., Просекова Е.В., Ковальчук В.К., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Кныш С.В., Малков В.А., Просекова Е.В., Ковальчук В.К.</copyright-holder><copyright-holder xml:lang="en">Knysh S.V., Malkov V.A., Prosekova E.V., Kovalchuk V.K.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.tmj-vgmu.ru/jour/article/view/279">https://www.tmj-vgmu.ru/jour/article/view/279</self-uri><abstract><p>Оценивали содержание интерферонов I, II и III типов в сыворотке крови 50 пациентов с опоясывающим герпесом и 30 здоровых добровольцев. У пациентов с герпесом обнаружено достоверное снижение содержания интерферонов ß, λ1, λ3 и λ1/3. Таким образом, при опоясывающем герпесе наблюдался выраженный дефицит интерферонов I и III типов. Выявлена положительная корреляционная связь между концентрациями всех трех типов интерферона. Показано, что повышенное содержание интерферона-γ ассоциировано с более легким течением заболевания.</p></abstract><trans-abstract xml:lang="en"><p>Objective. Study of mediators of immune system - is one of the main immunology direction. Interferons (IFN) are the most studied group of mediators. It includes three types of IFN - I type (a, ß, ы) with marked antiviral activity, II type (y) - whose main function is immune regulation. And III type (λ1, λ2, λ3, and λ4) with antitumor and antiviral activity. The aim of work: to study condition of IFN system by evaluating the serum level of IFN's in patients with herpes zoster. Methods. 50 patients with herpes zoster were examined. Serum was taken in first 72 hours after disease manifestation. The level of IFN-ß, IFN-γ, IFN-λ1, IFN-λ3, IFN-λ1/3 was determined by using specific reagents R&amp;D Diagnostics Inc. (USA). The data were presented as a median and two quartiles (Me, Q25, Q75). The interrelation of indicators was estimated by the Spearman correlation coefficient. Results. The serum level of IFN-ß, IFN-λ1, IFN-λ3, IFN-λ1/3 were significantly lower in patients with herpes zoster in comparison with the control group. Also, the weak positive correlation between IFN-ß and IFNλ1/3, IFN-ß and IFN-γ; and medium positive correlation between IFN-y and IFN-λ1/3 were established. Conclusions. The interferons deficiency was identified. Presumably the correlation between IFN-y and IFN-λ1/3 is due to common type of producer cell - plasmacytoid dendritic cells. In addition, the direct positive effect of IFN-λ on interleukin-12 (IL-12) and on NK-cells through IL-12 cause positive effect of IFN-λ to IFN-y. Disbalance in interferons ratio - one of the potent factors of varicella zoster virus reactivation. In addition, the high serum level of IFN-γ is a factor of mild course of disease.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>интерфероны</kwd><kwd>опоясывающий герпес</kwd></kwd-group><kwd-group xml:lang="en"><kwd>interferons</kwd><kwd>herpes zoster</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Кныш С.В., Маркелова Е.В., Невежкина Т.А. [и др.]. Уровень интерферона-лямбда-1 и интерферона-гамма в сыворотке крови пациентов с опоясывающим герпесом // Российский иммунологический журнал. 2017. Т. 11, № 4. С. 712-714</mixed-citation><mixed-citation xml:lang="en">Кныш С.В., Маркелова Е.В., Невежкина Т.А. [и др.]. Уровень интерферона-лямбда-1 и интерферона-гамма в сыворотке крови пациентов с опоясывающим герпесом // Российский иммунологический журнал. 2017. Т. 11, № 4. С. 712-714</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Симбирцев А.С. Цитокины в патогенезе и лечении заболеваний человека. СПб.: Фолиант, 2018. 512 с</mixed-citation><mixed-citation xml:lang="en">Симбирцев А.С. Цитокины в патогенезе и лечении заболеваний человека. СПб.: Фолиант, 2018. 512 с</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Скляр Л.Ф., Маркелова Е.В., Нагорная А.В., Сотниченко С.А. Особенности клиники и состояния врожденного иммунитета при сочетанных герпесвирусных менингоэнцефалитах у ВИЧ-инфицированных пациентов // Тихоокеанский медицинский журнал. 2014. № 1. С. 82-85</mixed-citation><mixed-citation xml:lang="en">Скляр Л.Ф., Маркелова Е.В., Нагорная А.В., Сотниченко С.А. Особенности клиники и состояния врожденного иммунитета при сочетанных герпесвирусных менингоэнцефалитах у ВИЧ-инфицированных пациентов // Тихоокеанский медицинский журнал. 2014. № 1. С. 82-85</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ank N., West H., Bartholdy C. [et al.]. Lambda interferon (IFN-Х), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo // Journal of Virology. 2006. Vol. 80, No. 9. P 4501-4509.</mixed-citation><mixed-citation xml:lang="en">Ank N., West H., Bartholdy C. [et al.]. Lambda interferon (IFN-Х), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo // Journal of Virology. 2006. Vol. 80, No. 9. P 4501-4509.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Baird N.L., Bowlin J.L., Hotz T.J. [et al.]. Interferon gamma prolongs survival of Varicella-Zoster virus infected human neurons in vitro // Journal ofVirology. 2015. Vol. 89, No. 14. P. 7425-7427.</mixed-citation><mixed-citation xml:lang="en">Baird N.L., Bowlin J.L., Hotz T.J. [et al.]. Interferon gamma prolongs survival of Varicella-Zoster virus infected human neurons in vitro // Journal ofVirology. 2015. Vol. 89, No. 14. P. 7425-7427.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Groen R.A., Boltjes A., Hou J. [et al.]. IFNA-mediated IL-12 production in macrophages induces IFN-γ production in human NK cells // Eur. J. Immunol. 2015. No. 45. P 250-259.</mixed-citation><mixed-citation xml:lang="en">Groen R.A., Boltjes A., Hou J. [et al.]. IFNA-mediated IL-12 production in macrophages induces IFN-γ production in human NK cells // Eur. J. Immunol. 2015. No. 45. P 250-259.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kim C.K., Choi Y.M., Bae E. [et al.]. Reduced NK cell IFN-y secretion and psychological stress are independently associated with herpes zoster. // PLoS ONE. Vol. 13, No 2. P. e0193299.</mixed-citation><mixed-citation xml:lang="en">Kim C.K., Choi Y.M., Bae E. [et al.]. Reduced NK cell IFN-y secretion and psychological stress are independently associated with herpes zoster. // PLoS ONE. Vol. 13, No 2. P. e0193299.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ku C.C., Chang Y.H., Chien Y., Lee T.L. Type I interferon inhibits varicella-zoster virus replication by interfering with the dynamic interaction between mediator and IE62 within replication compartments // Cell Biosci. 2016. Vol. 6 doi: 10.1186/s13578-016-0086-6.</mixed-citation><mixed-citation xml:lang="en">Ku C.C., Chang Y.H., Chien Y., Lee T.L. Type I interferon inhibits varicella-zoster virus replication by interfering with the dynamic interaction between mediator and IE62 within replication compartments // Cell Biosci. 2016. Vol. 6 doi: 10.1186/s13578-016-0086-6.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Li J., Ye L., Wang X. [et al.]. Induction of IFN-lambda contributes to TLR3-mediated HSV-1 inhibition in astrocytes // J. Neurosci. Res. 2012. Vol. 90, No. 2. P 399-406.</mixed-citation><mixed-citation xml:lang="en">Li J., Ye L., Wang X. [et al.]. Induction of IFN-lambda contributes to TLR3-mediated HSV-1 inhibition in astrocytes // J. Neurosci. Res. 2012. Vol. 90, No. 2. P 399-406.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Misumi I., Whitmire J.K. FN-lambda exerts opposing effects on T cell responses depending on the chronicity of the virus infection // J. Immunol. 2014. Vol. 192, No. 8. P 3596-3606.</mixed-citation><mixed-citation xml:lang="en">Misumi I., Whitmire J.K. FN-lambda exerts opposing effects on T cell responses depending on the chronicity of the virus infection // J. Immunol. 2014. Vol. 192, No. 8. P 3596-3606.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ng C.T., Sullivan B.M, Teijaro J.R. [et al.]. Blockade of interferon beta, but not interferon alpha, signaling controls persistent viral infection // Cell Host Microbe. 2015. Vol. 17, No 5. P. 653-661.</mixed-citation><mixed-citation xml:lang="en">Ng C.T., Sullivan B.M, Teijaro J.R. [et al.]. Blockade of interferon beta, but not interferon alpha, signaling controls persistent viral infection // Cell Host Microbe. 2015. Vol. 17, No 5. P. 653-661.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Petersen T., Moller-Larsen A., Ellermann-Eriksen S. [et al.]. Effects of interferon-beta therapy on elements in the antiviral immune response towards the human herpesviruses EBV, HSV, and VZV, and to the human endogenous retroviruses HERV-H and HERV-W in multiple sclerosis // Journal of Neuroimmunology. 2012. No. 249. P. 105-108.</mixed-citation><mixed-citation xml:lang="en">Petersen T., Moller-Larsen A., Ellermann-Eriksen S. [et al.]. Effects of interferon-beta therapy on elements in the antiviral immune response towards the human herpesviruses EBV, HSV, and VZV, and to the human endogenous retroviruses HERV-H and HERV-W in multiple sclerosis // Journal of Neuroimmunology. 2012. No. 249. P. 105-108.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Read S.A., O’Connor K.S., Suppiah V [et al.]. Zinc is a potent and specific inhibitor of IFN-X3 signalling // Nature communications. 2017. Vol. 8. doi: 10.1038/ncomms15245 (2017).</mixed-citation><mixed-citation xml:lang="en">Read S.A., O’Connor K.S., Suppiah V [et al.]. Zinc is a potent and specific inhibitor of IFN-X3 signalling // Nature communications. 2017. Vol. 8. doi: 10.1038/ncomms15245 (2017).</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Sen N., Arvin, A.M. Dissecting the molecular mechanisms ofthe tropism of Varicella-Zoster virus for human T cells // Journal of Virology. 2016. Vol. 90, No. 7. P. 3284-3287.</mixed-citation><mixed-citation xml:lang="en">Sen N., Arvin, A.M. Dissecting the molecular mechanisms ofthe tropism of Varicella-Zoster virus for human T cells // Journal of Virology. 2016. Vol. 90, No. 7. P. 3284-3287.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Yin Z., Dai J., Deng J. [et al.]. Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells // J. Immunol. 2012. Vol. 189, No. 6. P. 2735-2745.</mixed-citation><mixed-citation xml:lang="en">Yin Z., Dai J., Deng J. [et al.]. Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells // J. Immunol. 2012. Vol. 189, No. 6. P. 2735-2745.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
